Chargement en cours...
Cytotoxic T Lymphocyte Therapy for Epstein-Barr Virus(+) Hodgkin's Disease
Epstein Barr virus (EBV)(+) Hodgkin's disease (HD) expresses clearly identified tumor antigens derived from the virus and could, in principle, be a target for adoptive immunotherapy with viral antigen–specific T cells. However, like most tumor-associated antigens in immunocompetent hosts, these...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Rockefeller University Press
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2211993/ https://ncbi.nlm.nih.gov/pubmed/15611290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1084/jem.20040890 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|